News

As Eli Lilly and Novo Nordisk are scrambling to meet demand for their popular weight-loss drugs, Bristol-Myers Squibb is the latest drugmaker to wield the restructuring ax, with plans to cut $1.5 billion in costs by the end of 2025.

On May 8, Ascension Healthcare announced their clinical operations were disrupted by a "cyber security event".

Now, with only 6 months before the presidential election, the Biden administration is working to secure its health care policies, such as abortion data privacy, otherwise lawmakers may nullify new executive branch rules.

The Pfizer settlements come as GSK, a previous Zantac manufacturer, defends itself in an ongoing trial, while Sanofi, which recalled the drug in 2019 over cancer claims, agreed to pay more than $100 million to resolve its Zantac cases.

The BioButton, which attaches to the skin, has been used on more than 80,000 hospital patients nationwide in the past year, including those at Houston Methodist, which is the first hospital to use the AI tool to monitor patients.

Due to low unemployment and rising wages, Medicare's trust fund for hospital expenses will see its reserves depleted in 2036, and Social Security's funds will pay full benefits until 2035, according to a new report.

The health care industry has experienced significant consolidation in recent years, which has sparked concerns from the agencies that the consolidation has resulted in diminished choice, lower quality and increased health care costs.

Republican-led states have joined 1 of 2 lawsuits challenging the administration's Saving on a Valuable Education plan, which takes effect on July 1, unless the courts grant an injunction to prevent SAVE from being implemented.